Press - MIG Verwaltung EN

Süddeutsche Zeitung - Tue, 13. July 2021

Cold as Ice against the big Players

Portrait of Quantum Computing Start-up IQM, a MIG portfolio company.

Find out more

Trend - Mon, 12. July 2021

„This will be a big thing“

Online-interview with Dr. Matthias Kromayer, General Partner MIG AG, in leading Austrian Magazine „Trend“ about the future of Biotech and the portfolio of MIG Fonds.

Find out more

Bayerische Staatszeitung - Fri, 09. July 2021

„Quantum Computer are committing errors all the time"

Interview with Dr. Jan Goetz, CEO of IQM, a MIG portfolio company, about the opportunities and limits of Quantum Computing.

Find out more

Frankfurter Allgemeine Zeitung - Tue, 29. June 2021

Private Equity for small money

„FAZ“ is analyzing opportunities and risks of MIG Fonds.

Fiind out more

Tagesschau.de - Tue, 22. June 2021

Pro and Con of vaccinations of children

„tagesschau.de“ discusses aspects of vaccionations of children against Covid-19 – with quotes of Dr. Matthias Kromayer, General Partner MIG AG

Find out more

Handelsblatt - Wed, 16. June 2021

Macron demands till 2030 ten 100-Billion-Euro Start-ups

As part of a conference president Macron calls till 2030 the construction of ten European start-ups with a valuation of 100 Billion Euro. Among the participants Dr. Jan Goetz, CEO of IQM, a MIG portfolio company.

Find out more

Handelsblatt - Sat, 12. June 2021

Unexpected Growth

„Handelsblatt“ reports about the increasing significance of SiC technology for DAX firm Infineon. Base was the acquisition of Siltectra, a former MIG portfolio company.

Find out more

Frankfurter Allgemeine Zeitung - Thu, 10. June 2021

Qutac – German Industry forms alliance in Quantum Computing

„FAZ“ reports about Qutac, a project of the German industry refering Quantum Computing. MIG portfolio company IQM is part of Qutac.

Find out more

VC Magazin - Tue, 01. June 2021

The Young Wild from the North

Trade Magazine „VC Magazin“ portrays MIG portfolio company GWA Hygiene as an example of start-ups in Northern Germany

Find out more

Wirtschaftswoche - Sat, 22. May 2021

Sun, Beach – and now Start-ups

„Wirtschaftswoche“ describes the founders scene in Mecklenburg-Vorpommern with quotes of Tobias Gebhardt, CEO GWA Hygiene GmbH, a MIG portfolio company.

Find out more

Tagesschau.de - Fri, 21. May 2021

Technologies of the Future

ARD reports about biotechnology in Germany with a statement of Michael Motschmann, General Partner MIG AG.

Mehr erfahren

Going Public, Transkript - Tue, 11. May 2021

MIG: AMSilk Raises 29M Euro in Series C Funding

Several media report about the newest funding for AMSilk.

Find out more

Financial Times und WELT - Mon, 10. May 2021

Angela Merkel rejects US move to waive patents on vaccines

Among others „Financial Times“ and „DIE WELT“ report about the discussion to waive patents on Covid-19 vaccines, including quotes of Dr. Matthias Kromayer, General Partner MIG AG.

Find out more

Börsen Zeitung, Finanzwelt, et al. - Tue, 27. April 2021

MIG reports best year in history

Several media report about the best year in history of MIG AG

Find out more

Abendzeitung - Mon, 26. April 2021

„Politics should create incentives“

Interview with Michael Motschmann, General Partner MIG AG, in „Abendzeitung“ about the future of German Biotech.

Tagesschau.de - Wed, 21. April 2021

Advantage for mRNA-Vaccines

"tagesschau.de" has a look at the future of vaccinations against Covid-19 with quotes of Dr. Matthias Kromayer, General Partner MIG AG.

Mehr erfahren

dpa - Tue, 20. April 2021

Biotech expects

German News Agency "dpa" reports about the Biotech Business in Germany with quotes of Michael Motschmann, General Partner MIG AG. Around 150 media published the article of dpa, among them ...

Mehr erfahren

Münchner Merkur - Wed, 14. April 2021

How to bring buildings into a computer

„Münchner Merkur“ portrays NavVis, a MIG-portfolio company.

Manager Magazin - Fri, 02. April 2021

Quantum Computing – it starts to be serious

A podcast of „Manager Magazin“ explains the state of the art of Quantum Computing and mentions MIG portfolio company IQM as a leading player and Michael Motschmann, General Partner MIG AG, as investor.

Find out more

Manager Magazin - Wed, 24. March 2021

Biontech Investors put on Quantum Computing

„Manager Magazin Online“ reports about the assignment of Helmut Jeggle as Member of the Supervisory Board of IQM. The article mentions MIG Fonds and Michael Motschmann, Gneneral Partner of MIG AG, as first investor of the Finnish-German Start-up in Quantum Computing.

Find out more

Süddeutsche Zeitung - Sun, 21. March 2021

Super Quanten

„Süddeutsche Zeitung“ reports about an innovative Quantum Computing Project of Leibnitz Rechenzentrum (LRZ) in Garching/Munich integrating IQM, a MIG portfolio company.

Find out more

VC Magazin - Sun, 21. March 2021

„Investors got their money seven times back“

Interview with Michael Motschmann, General Partner of MIG AG, in „VC-Magazin“ about the investment in BioNTech

Find out more

Manager Magazin - Sat, 20. March 2021

Going viral

In an article about the German Biotech Industry „Manager Magazin“ quotes Dr. Matthias Kromayer, General Partner of MIG AG.

DIE WELT - Thu, 18. March 2021

„What in Germany is possible“ and „The Heroes of the German Vaccine Fairy Tale“

„DIE WELT“ describes the development of MIG portfolio company BioNTech und the founders. The article refers to the role of Michael Motschmann and Dr. Matthias Kromayer, General Partner of MIG AG. Additionally an interview in „DIE WELT“ with Michael Motschmann.

Find out more

Handelsblatt - Wed, 17. March 2021

Six Start-ups are the German Hope in Quantum Computing

„Handelsblatt“ mentions IQM, a MIG portfolio company, as one of the leading German start-ups in Quantum Computing

Find out more

Börse Online - Thu, 11. March 2021

Success with molecules

In an article about Biotech IPOs in the US, „Börse Online“ quotes Dr. Matthias Kromayer, General Partner MIG AG.

Find out more

Wirtschaftswoche - Fri, 05. March 2021

The next enemy will be tougher

„Wirtschaftswoche“ explains the future of MIG portfolio company BioNTech with quotes of Michael Motschmann, General Partner MIG AG.

Find out more

Handelsblatt - Wed, 03. March 2021

Serious deficits

Angela Merkel and other heads of government claim a digital pact. Dr. Jan Goetz, CEO of MIG portfolio company IQM, calls for an European approach to Quantum Computing.

Find out more

BioCentury - Mon, 01. March 2021

The dark of COVID-19 brings promise to Germany´s biotech scene

Trade publication „BioCentury“ quotes Michael Motschmann, General Partner of MIG AG, in an article about the future of German Biotech industry.

Find out more

Tagesschau.de - Sat, 27. February 2021

Many ideas, little money

„tagesschau.de“ reports about investments in Biotech in Germany and quotes Michael Motschmann, General Partner MIG AG.

Find out more

Finanzwelt, VC Magazin - Wed, 24. February 2021

Next MIG Invest in Medical Technology

Several Trade Magazines report about MIGs investment in new portfolio company Creative Balloons.

Find out more

CHEManager - Wed, 17. February 2021

The Deals of German Biotech Investors

Trade Magazin „CHEManager“ reports about German Investors in Biotech, among them MIGs investments.

Find out more

Börsen Zeitung - Fri, 12. February 2021

Record return for MIG because of Biontech

„Börsen Zeitung“ interviews Michael Motschmann, General Partner of MIG AG, about new developments at MIG

Finanzwelt - Fri, 12. February 2021

MIG Fonds expand in the French Alps

„Finanzwelt“ reports about a new investment of MIG Fonds in Zadient Technologies.

Find out more

Financial Times, Reuters, Manager Magazine et al - Thu, 04. February 2021

BioNTech Fund (MIG) pays 600m Euro dividend on back of vaccine success

International and national media among them „Financial Times“ and „Reuters“ report about the record payment of MIG Fonds of 600m Euro to investors.

Find out more

Manager Magazin - Fri, 29. January 2021

Everything started with a dream

„Manager Magazin“ interviews Michael Motschmann, General Partner of MIG AG, and Co-Investors Thomas Strüngmann and Helmut Jeggle about their joint involvement at BioNTech SE.

Find out more

Handelsblatt - Thu, 14. January 2021

Exosceletts reduce sick days

„Handelsblatt“ reports about the technology of GBS, a start-up producing exosceletts; MIG Fonds invested recently.

Find out more

Frankfurter Allgemeine Zeitung - Sat, 09. January 2021

MIG - Press Review

2021

Cold as Ice against the big Players

Portrait of Quantum Computing Start-up IQM, a MIG portfolio company.

„This will be a big thing“

Online-interview with Dr. Matthias Kromayer, General Partner MIG AG, in leading Austrian Magazine „Trend“ about the future of Biotech and the portfolio of MIG Fonds.

„Quantum Computer are committing errors all the time"

Interview with Dr. Jan Goetz, CEO of IQM, a MIG portfolio company, about the opportunities and limits of Quantum Computing.

Private Equity for small money

„FAZ“ is analyzing opportunities and risks of MIG Fonds.

Pro and Con of vaccinations of children

„tagesschau.de“ discusses aspects of vaccionations of children against Covid-19 – with quotes of Dr. Matthias Kromayer, General Partner MIG AG

Macron demands till 2030 ten 100-Billion-Euro Start-ups

As part of a conference president Macron calls till 2030 the construction of ten European start-ups with a valuation of 100 Billion Euro. Among the participants Dr. Jan Goetz, CEO of IQM, a MIG portfolio company.

Unexpected Growth

„Handelsblatt“ reports about the increasing significance of SiC technology for DAX firm Infineon. Base was the acquisition of Siltectra, a former MIG portfolio company.

Qutac – German Industry forms alliance in Quantum Computing

„FAZ“ reports about Qutac, a project of the German industry refering Quantum Computing. MIG portfolio company IQM is part of Qutac.

The Young Wild from the North

Trade Magazine „VC Magazin“ portrays MIG portfolio company GWA Hygiene as an example of start-ups in Northern Germany

Sun, Beach – and now Start-ups

„Wirtschaftswoche“ describes the founders scene in Mecklenburg-Vorpommern with quotes of Tobias Gebhardt, CEO GWA Hygiene GmbH, a MIG portfolio company.

Technologies of the Future

ARD reports about biotechnology in Germany with a statement of Michael Motschmann, General Partner MIG AG.

MIG: AMSilk Raises 29M Euro in Series C Funding

Several media report about the newest funding for AMSilk.

Angela Merkel rejects US move to waive patents on vaccines

Among others „Financial Times“ and „DIE WELT“ report about the discussion to waive patents on Covid-19 vaccines, including quotes of Dr. Matthias Kromayer, General Partner MIG AG.

MIG reports best year in history

Several media report about the best year in history of MIG AG

„Politics should create incentives“

Interview with Michael Motschmann, General Partner MIG AG, in „Abendzeitung“ about the future of German Biotech.

Advantage for mRNA-Vaccines

"tagesschau.de" has a look at the future of vaccinations against Covid-19 with quotes of Dr. Matthias Kromayer, General Partner MIG AG.

Biotech expects

German News Agency "dpa" reports about the Biotech Business in Germany with quotes of Michael Motschmann, General Partner MIG AG. Around 150 media published the article of dpa, among them ...

„Münchner Merkur“ portrays NavVis, a MIG-portfolio company.

A podcast of „Manager Magazin“ explains the state of the art of Quantum Computing and mentions MIG portfolio company IQM as a leading player and Michael Motschmann, General Partner MIG AG, as investor.

„Manager Magazin Online“ reports about the assignment of Helmut Jeggle as Member of the Supervisory Board of IQM. The article mentions MIG Fonds and Michael Motschmann, Gneneral Partner of MIG AG, as first investor of the Finnish-German Start-up in Quantum Computing.

Super Quanten

„Süddeutsche Zeitung“ reports about an innovative Quantum Computing Project of Leibnitz Rechenzentrum (LRZ) in Garching/Munich integrating IQM, a MIG portfolio company.

„Investors got their money seven times back“

Interview with Michael Motschmann, General Partner of MIG AG, in „VC-Magazin“ about the investment in BioNTech

In an article about the German Biotech Industry „Manager Magazin“ quotes Dr. Matthias Kromayer, General Partner of MIG AG.

„What in Germany is possible“ and „The Heroes of the German Vaccine Fairy Tale“

„DIE WELT“ describes the development of MIG portfolio company BioNTech und the founders. The article refers to the role of Michael Motschmann and Dr. Matthias Kromayer, General Partner of MIG AG. Additionally an interview in „DIE WELT“ with Michael Motschmann.

Six Start-ups are the German Hope in Quantum Computing

„Handelsblatt“ mentions IQM, a MIG portfolio company, as one of the leading German start-ups in Quantum Computing

Success with molecules

In an article about Biotech IPOs in the US, „Börse Online“ quotes Dr. Matthias Kromayer, General Partner MIG AG.

The next enemy will be tougher

„Wirtschaftswoche“ explains the future of MIG portfolio company BioNTech with quotes of Michael Motschmann, General Partner MIG AG.

Serious deficits

Angela Merkel and other heads of government claim a digital pact. Dr. Jan Goetz, CEO of MIG portfolio company IQM, calls for an European approach to Quantum Computing.

The dark of COVID-19 brings promise to Germany´s biotech scene

Trade publication „BioCentury“ quotes Michael Motschmann, General Partner of MIG AG, in an article about the future of German Biotech industry.

Many ideas, little money

„tagesschau.de“ reports about investments in Biotech in Germany and quotes Michael Motschmann, General Partner MIG AG.

Next MIG Invest in Medical Technology

Several Trade Magazines report about MIGs investment in new portfolio company Creative Balloons.

The Deals of German Biotech Investors

Trade Magazin „CHEManager“ reports about German Investors in Biotech, among them MIGs investments.

Record return for MIG because of Biontech

„Börsen Zeitung“ interviews Michael Motschmann, General Partner of MIG AG, about new developments at MIG

MIG Fonds expand in the French Alps

„Finanzwelt“ reports about a new investment of MIG Fonds in Zadient Technologies.

BioNTech Fund (MIG) pays 600m Euro dividend on back of vaccine success

International and national media among them „Financial Times“ and „Reuters“ report about the record payment of MIG Fonds of 600m Euro to investors.

„Manager Magazin“ interviews Michael Motschmann, General Partner of MIG AG, and Co-Investors Thomas Strüngmann and Helmut Jeggle about their joint involvement at BioNTech SE.

Exosceletts reduce sick days

„Handelsblatt“ reports about the technology of GBS, a start-up producing exosceletts; MIG Fonds invested recently.

Screen Supplier to sell

„FAZ“ reports about the start of a trade sale of Cynora, a portfolio company of MIG Fonds.